Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Beyond ML Groups CEO Lan Huang On How To Bridge The Gap Between U.S. Biopharma Companies And China CROs: An Interview with PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

New York-based Beyond ML Groups provides consulting service to big pharmas, biotech companies, hedge funds and VC firms and specializes in helping them develop business strategies in China. The company also has an investment division targeting the China CRO industry. CEO and Founder Lan Huang talked to PharmAsia News' Shanghai bureau about the culture differences between China and U.S. companies and how the global financial crisis is affecting China's CRO industry.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts